Zealand Pharma's petrelintide shows weight loss in Type 2 diabetes trial

October 7, 2026 1:14 PM

Zealand Pharma A/S (Nasdaq: ZEAL) reported positive topline results from its Phase 2 ZUPREME-2 trial, in which the amylin analog ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found